EP Patent

EP4288151A1 — Topical ophthalmological compositions

Assigned to ADS Therapeutics LLC · Expires 2023-12-13 · 2y expired

What this patent protects

A topical ophthalmological composition includes a muscarinic receptor antagonist as an active pharmaceutical ingredient; and medium chain triglycerides (MCTs) or light liquid paraffin oil as liquid vehicle. The topical ophthalmological composition treats an ocular disease.

USPTO Abstract

A topical ophthalmological composition includes a muscarinic receptor antagonist as an active pharmaceutical ingredient; and medium chain triglycerides (MCTs) or light liquid paraffin oil as liquid vehicle. The topical ophthalmological composition treats an ocular disease.

Drugs covered by this patent

phenylephrine-hydrochloride (PHENYLEPHRINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP4288151A1
Jurisdiction: EP
Classification: —
Expires: 2023-12-13
Drug substance claim: No
Drug product claim: No
Assignee: ADS Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.